SRC and breast carcinoma: There are also many investigational Src inhibitors (some with more specificity towards Src, including PP1 [126] and PP2 [127], SU6656, KX1-004 [128], eCF506, DGY-06-116 [129], and Src inhibitor-1 [130]) that have not reached clinical trials in breast cancer yet.